Learn about clinical, research advances at booth 713
From age-related macular degeneration treatment advances to artificial vision, Cleveland Clinic’s ophthalmology experts will be talking about leading-edge research at our booth (713) at the 2019 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Vancouver.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cole Eye Institute Chair Daniel F. Martin, MD, invites you to meet our presenters for lively discussions. Here’s the booth schedule:
10-11 a.m. Rishi Singh, MD
12-1 p.m. George Hoppe, PhD
2-3 p.m. Alex Yuan, MD, PhD
10-11 a.m. Bela Anand-Apte, MD, PhD
12-1 p.m. Rachel Chen, MD
2-3 p.m. Fatema Ghasia, MD
10-11 a.m. Connie Tam, PhD
12-1 p.m. Sujata Rao, PhD
2-3 p.m. Vera Bonilha, PhD
Advertisement
Advertisement
International collaboration is most genetically diverse study of the disease to date
Preclinical work promises large-scale data with minimal bias to inform development of clinical tests
Matching SNOMED Term with Curated Post. Please do not touch this post or any of its categories/snomed terms, thank you!
Matching Primary -> Secondary SNOMED Term with Curated Post. Please do not touch this post or any of its categories/snomed terms, thank you!
Cleveland Clinic researchers pursue answers on basic science and clinical fronts
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
Cleveland Clinic launches Quantum Innovation Catalyzer Program to help start-up companies access advanced research technology